Alan P. Venook, MD of University of California San Francisco discusses integrating TAS-102 and regorafenib into your therapeutic algorithm for advanced CRC at ASCO GI 2016
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content